TP53 and liver cancer: It was found that p53 levels are also affected by the addition of cjoc42 in the liver cancer cell line HepG2 where gankyrin expression is a key oncogenic driver, indicating that the compound can affect endogenous gankyrin in a manner similar to that observed for gankyrin over-expressed by transfection (Supplementary Fig. S16).